The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Assuring the quality of next-generation sequencing in clinical laboratory practice
Open accessAbstract
To the Editor: We direct your readers’ attention to the principles and guidelines (Supplementary Guidelines) developed by the Nextgeneration Sequencing: Standardization of Clinical Testing (Nex-StoCT) workgroup. These guidelines represent initial steps to ensure that results from tests based on nextgeneration sequencing (NGS) are reliable and useful for clinical decision making. The US Centers for Disease Control and Prevention (CDC) convened this national workgroup, which collaborated to define platform-independent approaches for establishing technical process elements of a quality management system (QMS) to assure the analytical validity and compliance of NGS tests with existing regulatory and professional quality standards. The workgroup identified and addressed gaps in quality practices that could compromise the quality of both clinical laboratory services and translational efforts needed to advance the implementation and utility of NGS in clinical settings. The workgroup was composed of experts with knowledge of and experience with NGS and included clinical laboratory directors, clinicians, platform and software developers and informaticians, as well as individuals actively engaged in NGS guideline development from accreditation bodies and professional organizations. Representatives from US government agencies also participated. These guidelines address four topics that are components of quality management in a clinical environment: (i) test validation, (ii) quality control (QC) procedures to assure and maintain accurate test results, (iii) the independent assessment of test performance through proficiency testing (PT) or alternative approaches and (iv) reference materials (RMs). Discussions were limited to the analytic and informatics processes required for accurate variant calling. The workgroup did not address how variants are prioritized, interpreted or reported. The workgroup recommendations are summarized in Table 1. Although the workgroup focused on detection of DNA sequence variations associated with heritable human disorders, many of the principles and recommendations described are also relevant to the application of NGS to other areas of laboratory medicine, including the diagnosis, prognosis and treatment of cancer and infectious-disease testing. Validation is the process of establishing analytical performance specifications for a clinical test system developed in house to confirm that the system is suitable for its intended use1. During the validation process, the laboratory must demonstrate that the assay functions as expected and provides
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
The variant call format and VCFtools
Danecek, P., Auton, A., Abecasis, G., Albers, C. A., Banks, E., DePristo, M. A., Handsaker, R. E., Lunter, G., Marth, G. T., Sherry, S. T., et al. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr330 · Cited by 16,200
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
International Organization for Standardization
(2011) · SpringerReference · doi:10.1007/springerreference_16847 · Cited by 12,534
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
<tt>BLAT</tt> —The <tt>BLAST</tt> -Like Alignment Tool
Kent, W. J. (2002) · Genome Research · doi:10.1101/gr.229202 · Cited by 8,480
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066
International Organization for Standardization
(2015) · Encyclopedia of Astrobiology · doi:10.1007/978-3-662-44185-5_100574 · Cited by 6,716
Cited by
Coming of age: ten years of next-generation sequencing technologies
Goodwin, S., McPherson, J. D., & McCombie, W. R. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.49 · Cited by 4,352
Ultrafast one‐pass FASTQ data preprocessing, quality control, and deduplication using fastp
Chen, S. (2023) · iMeta · doi:10.1002/imt2.107 · Cited by 2,166
Frampton, G. M., Fichtenholtz, A., Otto, G. A., Wang, K., Downing, S. R., He, J., Schnall-Levin, M., White, J., Sanford, E. M., An, P., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2696 · Cited by 2,157
Guidelines for investigating causality of sequence variants in human disease
MacArthur, D. G., Manolio, T. A., Dimmock, D. P., Rehm, H. L., Shendure, J., Abecasis, G. R., Adams, D. R., Altman, R. B., Antonarakis, S. E., Ashley, E. A., et al. (2014) · Nature · doi:10.1038/nature13127 · Cited by 1,224
Self-citationTumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,211
ACMG clinical laboratory standards for next-generation sequencing
Rehm, H. L., Bale, S. J., Bayrak-Toydemir, P., Berg, J. S., Brown, K. K., Deignan, J. L., Friez, M. J., Funke, B. H., Hegde, M. R., & Lyon, E. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.92 · Cited by 907
Self-citationGuidelines for Validation of Next-Generation Sequencing–Based Oncology Panels
Jennings, L. J., Arcila, M. E., Corless, C., Kamel-Reid, S., Lubin, I. M., Pfeifer, J., Temple-Smolkin, R. L., Voelkerding, K. V., & Nikiforova, M. N. (2017) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.01.011 · Cited by 743
Self-citationLanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695
Lee, I., Chalita, M., Ha, S.-M., Na, S.-I., Yoon, S.-H., & Chun, J. (2017) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.001872 · Cited by 578
Best practices for benchmarking germline small-variant calls in human genomes
the Global Alliance for Genomics and Health Benchmarking Team, Krusche, P., Trigg, L., Boutros, P. C., Mason, C. E., De La Vega, F. M., Moore, B. L., Gonzalez-Porta, M., Eberle, M. A., Tezak, Z., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0054-x · Cited by 429
Self-citationBuilding the foundation for genomics in precision medicine
Aronson, S. J., & Rehm, H. L. (2015) · Nature · doi:10.1038/nature15816 · Cited by 492
Self-citationNaccache, S. N., Federman, S., Veeraraghavan, N., Zaharia, M., Lee, D., Samayoa, E., Bouquet, J., Greninger, A. L., Luk, K.-C., Enge, B., et al. (2014) · Genome Research · doi:10.1101/gr.171934.113 · Cited by 460
Erratum: Guidelines for diagnostic next-generation sequencing
Matthijs, G., Souche, E., Alders, M., Corveleyn, A., Eck, S., Feenstra, I., Race, V., Sistermans, E., Sturm, M., Weiss, M., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.63 · Cited by 430
Using Genomics to Track Global Antimicrobial Resistance
Hendriksen, R. S., Bortolaia, V., Tate, H., Tyson, G. H., Aarestrup, F. M., & McDermott, P. F. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00242 · Cited by 425
Prognostic and predictive biomarkers in breast cancer: Past, present and future
Nicolini, A., Ferrari, P., & Duffy, M. J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.010 · Cited by 424
DGIdb 2.0: mining clinically relevant drug–gene interactions
Wagner, A. H., Coffman, A. C., Ainscough, B. J., Spies, N. C., Skidmore, Z. L., Campbell, K. M., Krysiak, K., Pan, D., McMichael, J. F., Eldred, J. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1165 · Cited by 413
Self-citationCollege of American Pathologists' Laboratory Standards for Next-Generation Sequencing Clinical Tests
Aziz, N., Zhao, Q., Bry, L., Driscoll, D. K., Funke, B., Gibson, J. S., Grody, W. W., Hegde, M. R., Hoeltge, G. A., Leonard, D. G. B., et al. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0250-cp · Cited by 387
Self-citationReview of Clinical Next-Generation Sequencing
Yohe, S., & Thyagarajan, B. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0501-ra · Cited by 370
Next-generation sequencing and its clinical application
Dahui, Q. (2019) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2018.0055 · Cited by 333
Implementing personalized cancer genomics in clinical trials
Simon, R., & Roychowdhury, S. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3979 · Cited by 301
Targeted Next-Generation Sequencing can Replace Sanger Sequencing in Clinical Diagnostics
Sikkema-Raddatz, B., Johansson, L. F., de Boer, E. N., Almomani, R., Boven, L. G., van den Berg, M. P., van Spaendonck-Zwarts, K. Y., van Tintelen, J. P., Sijmons, R. H., Jongbloed, J. D. H., et al. (2013) · Human Mutation · doi:10.1002/humu.22332 · Cited by 300
The current state of molecular testing in the treatment of patients with solid tumors, 2019
El‐Deiry, W. S., Goldberg, R. M., Lenz, H., Shields, A. F., Gibney, G. T., Tan, A. R., Brown, J., Eisenberg, B., Heath, E. I., Phuphanich, S., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21560 · Cited by 264
High Throughput Sequencing for Detection of Foodborne Pathogens
Sekse, C., Holst-Jensen, A., Dobrindt, U., Johannessen, G. S., Li, W., Spilsberg, B., & Shi, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02029 · Cited by 98
Advances in technologies for screening and diagnosis of hemoglobinopathies
Traeger-Synodinos, J., & Harteveld, C. L. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.13.103 · Cited by 53
Metadata
- Authors
- Gargis, A. S., Kalman, L., Berry, M. W., Bick, D. P., Dimmock, D. P., Hambuch, T., Lu, F., Lyon, E., Voelkerding, K. V., Zehnbauer, B. A., Agarwala, R., Bennett, S. F., Chen, B., Chin, E. L. H., Compton, J. G., Das, S., Farkas, D. H., Ferber, M. J., Funke, B. H., Furtado, M. R., Ganova-Raeva, L. M., Geigenmüller, U., Gunselman, S. J., Hegde, M. R., Johnson, P. L. F., Kasarskis, A., Kulkarni, S., Lenk, T., Liu, C. S. J., Manion, M., Manolio, T. A., Mardis, E. R., Merker, J. D., Rajeevan, M. S., Reese, M. G., Rehm, H. L., Simen, B. B., Yeakley, J. M., Zook, J. M., & Lubin, I. M.
- Venue
- Nature Biotechnology
- Published
- 2012-11
- Volume
- 30
- Issue
- 11
- Pages
- 1033-1036
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2159265519
- Cited by
- 461
- References
- 55
- FWCI
- 30.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.